Skip to main content
. 2021 Feb 17;11:3991. doi: 10.1038/s41598-021-83603-4

Figure 2.

Figure 2

Suppression of NF-κB reduces HIF-1α expression and glucose metabolism in MYD88 L265P-expressing p53−/−MEFs. (ad) Suppression of NF-κB using IκB SR in p53−/−MEFs expressing MYD88 L265P. (a) Total cell lysates were analysed by immunoblotting. The arrow indicates phosphorylated-IκBα and the asterisk indicates a nonspecific band. (b) Gene expression of NF-κB targets measured by qPCR. (c) Expression of glucose metabolism-related genes were quantified by qPCR. (d) Glucose uptake and lactate production were measured. The quantified results are presented as the mean ± s.d. (n = 4) using one-way ANOVA followed by Scheffe’s F test. *P < 0.05, **P < 0.01. (e,f) p53−/−MEFs were treated with LPS and IL-1β for the indicated times. (g) Endogenous MYD88 expression were reduced by shRNA (#1 and #2), then these cells were stimulated with LPS for the indicated times. (b,c) The y-axis values are relative fold change for gene transcripts normalised to β-actin. Data represent the mean ± s.d. (n = 3) using one-way ANOVA followed by Scheffe’s F test. *P < 0.05, **P < 0.01.